Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
Classic Kaposi's sarcoma (KS) is a disease with low mortality but high morbidity. The optimum treatment of KS depends upon several factors, including location of lesions, disease progression, severity of symptoms and patient preference. We report the long-term response to the use of intralesion...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2015-02-01
|
Series: | Case Reports in Dermatology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/369490 |
_version_ | 1828492730471284736 |
---|---|
author | Yasir Azim Mirza Davide Altamura Torkan Hirbod Roberto Verdolini |
author_facet | Yasir Azim Mirza Davide Altamura Torkan Hirbod Roberto Verdolini |
author_sort | Yasir Azim Mirza |
collection | DOAJ |
description | Classic Kaposi's sarcoma (KS) is a disease with low mortality but high morbidity. The optimum treatment of KS depends upon several factors, including location of lesions, disease progression, severity of symptoms and patient preference. We report the long-term response to the use of intralesional doxorubicin to successfully treat a large cutaneous lesion of KS on a patient refractory to traditional treatments. |
first_indexed | 2024-12-11T11:25:43Z |
format | Article |
id | doaj.art-df8ec8ce0db14b3bab4d4f45b3c09d4f |
institution | Directory Open Access Journal |
issn | 1662-6567 |
language | English |
last_indexed | 2024-12-11T11:25:43Z |
publishDate | 2015-02-01 |
publisher | Karger Publishers |
record_format | Article |
series | Case Reports in Dermatology |
spelling | doaj.art-df8ec8ce0db14b3bab4d4f45b3c09d4f2022-12-22T01:09:01ZengKarger PublishersCase Reports in Dermatology1662-65672015-02-0171171910.1159/000369490369490Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case ReportYasir Azim MirzaDavide AltamuraTorkan HirbodRoberto VerdoliniClassic Kaposi's sarcoma (KS) is a disease with low mortality but high morbidity. The optimum treatment of KS depends upon several factors, including location of lesions, disease progression, severity of symptoms and patient preference. We report the long-term response to the use of intralesional doxorubicin to successfully treat a large cutaneous lesion of KS on a patient refractory to traditional treatments.http://www.karger.com/Article/FullText/369490Kaposiߣs sarcomaIntralesional doxorubicinTreatmentClassic Kaposiߣs sarcoma |
spellingShingle | Yasir Azim Mirza Davide Altamura Torkan Hirbod Roberto Verdolini Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report Case Reports in Dermatology Kaposiߣs sarcoma Intralesional doxorubicin Treatment Classic Kaposiߣs sarcoma |
title | Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report |
title_full | Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report |
title_fullStr | Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report |
title_full_unstemmed | Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report |
title_short | Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report |
title_sort | long term response of classic kaposi s sarcoma to intralesional doxorubicin a case report |
topic | Kaposiߣs sarcoma Intralesional doxorubicin Treatment Classic Kaposiߣs sarcoma |
url | http://www.karger.com/Article/FullText/369490 |
work_keys_str_mv | AT yasirazimmirza longtermresponseofclassickaposissarcomatointralesionaldoxorubicinacasereport AT davidealtamura longtermresponseofclassickaposissarcomatointralesionaldoxorubicinacasereport AT torkanhirbod longtermresponseofclassickaposissarcomatointralesionaldoxorubicinacasereport AT robertoverdolini longtermresponseofclassickaposissarcomatointralesionaldoxorubicinacasereport |